Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. HCA
stocks logo

HCA

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
19.66B
+7.53%
7.464
+20.01%
19.18B
+4.71%
7.194
+11.53%
19.43B
+4.43%
7.511
+9.81%
Estimates Revision
The market is revising Upward the revenue expectations for HCA Healthcare, Inc. (HCA) for FY2025, with the revenue forecasts being adjusted by 0.88% over the past three months. During the same period, the stock price has changed by 18.48%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.88%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+4.9%
In Past 3 Month
Stock Price
Go Up
up Image
+18.48%
In Past 3 Month
Wall Street analysts forecast HCA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCA is 481.33 USD with a low forecast of 417.00 USD and a high forecast of 525.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
19 Analyst Rating
Wall Street analysts forecast HCA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCA is 481.33 USD with a low forecast of 417.00 USD and a high forecast of 525.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Buy
6 Hold
0 Sell
Moderate Buy
Current: 487.660
sliders
Low
417.00
Averages
481.33
High
525.00
Current: 487.660
sliders
Low
417.00
Averages
481.33
High
525.00
Wells Fargo
Equal Weight
maintain
$412 -> $431
2025-11-13
Reason
Wells Fargo
Price Target
$412 -> $431
2025-11-13
maintain
Equal Weight
Reason
Wells Fargo raised the firm's price target on HCA Healthcare to $431 from $412 and keeps an Equal Weight rating on the shares following quarterly results. Overall, modestly higher EBITDA estimates and rolling fully to 2027 estimates offsets a material increase in the odds of enhanced exchange subsidies expiring in the firm's price target framework, Wells says.
Jefferies
Buy
maintain
$485 -> $525
2025-10-28
Reason
Jefferies
Price Target
$485 -> $525
2025-10-28
maintain
Buy
Reason
Jefferies raised the firm's price target on HCA Healthcare to $525 from $485 and keeps a Buy rating on the shares after "a good Q3, with a solid EBITDA beat." The magnitude of the Q3 beat highlighted how significant the upside could be from other upcoming state-directed payments approvals and made investors overlook the impasse in Congress over health insurance exchange subsidies, the analyst contends.
Oppenheimer
Oppenheimer
Outperform
maintain
$400 -> $500
2025-10-27
Reason
Oppenheimer
Oppenheimer
Price Target
$400 -> $500
2025-10-27
maintain
Outperform
Reason
Oppenheimer raised the firm's price target on HCA Healthcare to $500 from $400 and keeps an Outperform rating on the shares. The firm notes the company reported strong Q3 results, driven by revenue-per-adjusted admission, largely due to outsized tailwinds from state supplemental payments, along with other factors, which implies high single-digit growth for Q4 2025 after adjusting for the moving parts from supp. payments and the hurricanes from last year.
Cantor Fitzgerald
Sarah James
Overweight
maintain
$444 -> $525
2025-10-27
Reason
Cantor Fitzgerald
Sarah James
Price Target
$444 -> $525
2025-10-27
maintain
Overweight
Reason
Cantor Fitzgerald analyst Sarah James raised the firm's price target on HCA Healthcare to $525 from $444 and keeps an Overweight rating on the shares. HCA Heatlhcare's operational excellence persists as it paves an achievable path to 2025 guidance and an optimistic 2026 outlook, the analyst tells investors in a research note. Preliminary 2026 commentary suggests fundamentals are well-intact, the firm adds.
Goldman Sachs
Scott Fidel
Buy
maintain
$470 -> $520
2025-10-27
Reason
Goldman Sachs
Scott Fidel
Price Target
$470 -> $520
2025-10-27
maintain
Buy
Reason
Goldman Sachs analyst Scott Fidel raised the firm's price target on HCA Healthcare to $520 from $470 and keeps a Buy rating on the shares.
Morgan Stanley
Equal Weight
maintain
$400 -> $425
2025-10-27
Reason
Morgan Stanley
Price Target
$400 -> $425
2025-10-27
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on HCA Healthcare to $425 from $400 and keeps an Equal Weight rating on the shares. Q3 results "underscore solid execution," but "it may be time for a breather" following a strong run up in the stock, the analyst tells investors in a post-earnings note. With the stock up 30% since the Q2 report in late July, the stock could consolidate, though HCA is executing well and remains a bellwether in the group, the analyst added.
See All Ratings

Valuation Metrics

The current forward P/E ratio for HCA Healthcare Inc (HCA.N) is 16.58, compared to its 5-year average forward P/E of 13.75. For a more detailed relative valuation and DCF analysis to assess HCA Healthcare Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average PE
13.75
Current PE
16.58
Overvalued PE
15.38
Undervalued PE
12.13

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
8.94
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
9.62
Undervalued EV/EBITDA
8.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.16
Current PS
0.00
Overvalued PS
1.29
Undervalued PS
1.02
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

HCA News & Events

Events Timeline

(ET)
2025-10-24
07:29:07
HCA Healthcare increases FY25 adjusted EPS forecast to $27.00-$28.00, up from $25.50-$27.00
select
2025-10-24
07:26:41
HCA Healthcare announces Q3 adjusted earnings per share of $6.96, surpassing consensus estimate of $5.73.
select
2025-10-23 (ET)
2025-10-23
20:25:00
Major companies set to report earnings before tomorrow's market opening
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
6.5
12-02Barron's
16 Strong Stocks to Hold During Market Volatility
  • Market Rebound: The market has shown a significant recovery recently.
  • Expected Volatility: Despite the rebound, further volatility is anticipated in the market.
  • Investment Strategy: Investors are advised to consider high-quality stocks for protection.
  • Risk Management: Focusing on quality stocks can help mitigate potential risks in a volatile market.
[object Object]
Preview
4.5
11-25CNBC
Key Stock Developments on Tuesday: Factors That May Influence the Market in the Upcoming Trading Session
  • Market Overview: Gold remains flat over the last month but has increased by 10% over the past two months, while Bitcoin and Ether have seen significant declines of 20% and 25% respectively in the last month.

  • Ross Stores Performance: Ross Stores reached an all-time high, with its stock up 10% in November and 27% over the last six months, contrasting with the State Street SPDR S&P Retail ETF, which is down 1.8% in November.

  • Michael Burry's AI Concerns: Investor Michael Burry has launched a Substack newsletter to express his bearish views on artificial intelligence, coinciding with a deregistration of his hedge fund focused on AI stocks.

  • Healthcare Sector Gains: Stocks in the healthcare sector, such as Centene and Universal Health, experienced gains following comments from Treasury Secretary Scott Bessent about potential plans to lower healthcare costs.

[object Object]
Preview
8.0
11-22Newsfilter
Hamilton ETFs Reveals Monthly and Upcoming Semi-Monthly Cash Distributions for November 2025
  • Monthly and Semi-Monthly Distributions: Hamilton Capital Partners Inc. announced upcoming cash distributions for its ETFs, with monthly distributions expected to be paid on December 5, 2025, and semi-monthly distributions scheduled for December 5, 15, and 22, 2025.

  • Ex-Dividend Dates: The ex-dividend date for the monthly distributions is anticipated to be November 28, 2025, for all unitholders of record on that date.

  • Diverse ETF Offerings: Hamilton ETFs offers a range of ETFs that pay monthly and semi-monthly distributions, including various sector-focused funds such as financials, utilities, and technology.

  • Company Overview: Hamilton ETFs manages over $11 billion in assets and is recognized as one of Canada's fastest-growing ETF providers, focusing on maximizing income and growth through innovative investment strategies.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is HCA Healthcare Inc (HCA) stock price today?

The current price of HCA is 487.66 USD — it has increased 0.18 % in the last trading day.

arrow icon

What is HCA Healthcare Inc (HCA)'s business?

HCA Healthcare, Inc. is a health care services company. It owns, manages or operates hospitals, ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, hospices, and various other facilities. Its general, acute care hospitals provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Its behavioral hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. It operates approximately 190 hospitals and 2,400 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.

arrow icon

What is the price predicton of HCA Stock?

Wall Street analysts forecast HCA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCA is 481.33 USD with a low forecast of 417.00 USD and a high forecast of 525.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is HCA Healthcare Inc (HCA)'s revenue for the last quarter?

HCA Healthcare Inc revenue for the last quarter amounts to 19.16B USD, increased 9.57 % YoY.

arrow icon

What is HCA Healthcare Inc (HCA)'s earnings per share (EPS) for the last quarter?

HCA Healthcare Inc. EPS for the last quarter amounts to 6.96 USD, increased 42.33 % YoY.

arrow icon

What changes have occurred in the market's expectations for HCA Healthcare Inc (HCA)'s fundamentals?

The market is revising Upward the revenue expectations for HCA Healthcare, Inc. (HCA) for FY2025, with the revenue forecasts being adjusted by 0.88% over the past three months. During the same period, the stock price has changed by 18.48%.
arrow icon

How many employees does HCA Healthcare Inc (HCA). have?

HCA Healthcare Inc (HCA) has 226000 emplpoyees as of December 05 2025.

arrow icon

What is HCA Healthcare Inc (HCA) market cap?

Today HCA has the market capitalization of 111.28B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free